Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oriel J Feldman

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Expert Opinion on Emerging Drugs|June 1, 2024
Emerging therapies for treatment of agitation, psychosis, or apathy in Alzheimer's diseaseHui Jue Wang, Arun Chinna-Meyyappan, Oriel J Feldman, et al.
Frontiers in Medicine|September 1, 2022
Sex differences in clinical trials of ALRV5XR treatment of androgenetic alopecia and telogen effluviumPeter R Feldman, Oriel J Feldman, Jaime Guevara-Aguirre, et al.
Current Topics in Behavioral Neurosciences|January 24, 2025
Behavioral and Psychological Symptoms (BPSD) in Alzheimer's Disease (AD): Development and TreatmentHyewon H Lee, Arun Chinnameyyappan, Oriel J Feldman, et al.
International Psychogeriatrics|January 13, 2026
Assessment of clinical factors that predict response to nabilone for agitation in Alzheimer's disease: A post hoc analysis of a randomized placebo-controlled trialOriel J Feldman, Nathan Herrmann, Myuri Ruthirakuhan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Clinical ManifestationsOriel J Feldman, Myuri Ruthirakuhan, Nathan Herrmann, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Clinical ManifestationsHui Jue Janet Wang, Myuri Ruthirakuhan, Nathan Herrmann, et al.
Frontiers in Medicine|February 9, 2023
Hair regrowth treatment efficacy and resistance in androgenetic alopecia: A systematic review and continuous Bayesian network meta-analysisPeter R Feldman, Pietro Gentile, Charles Piwko, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Expert Opinion on Emerging Drugs|June 1, 2024
Emerging therapies for treatment of agitation, psychosis, or apathy in Alzheimer's diseaseHui Jue Wang, Arun Chinna-Meyyappan, Oriel J Feldman, et al.
Frontiers in Medicine|September 1, 2022
Sex differences in clinical trials of ALRV5XR treatment of androgenetic alopecia and telogen effluviumPeter R Feldman, Oriel J Feldman, Jaime Guevara-Aguirre, et al.
Current Topics in Behavioral Neurosciences|January 24, 2025
Behavioral and Psychological Symptoms (BPSD) in Alzheimer's Disease (AD): Development and TreatmentHyewon H Lee, Arun Chinnameyyappan, Oriel J Feldman, et al.
International Psychogeriatrics|January 13, 2026
Assessment of clinical factors that predict response to nabilone for agitation in Alzheimer's disease: A post hoc analysis of a randomized placebo-controlled trialOriel J Feldman, Nathan Herrmann, Myuri Ruthirakuhan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Clinical ManifestationsOriel J Feldman, Myuri Ruthirakuhan, Nathan Herrmann, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Clinical ManifestationsHui Jue Janet Wang, Myuri Ruthirakuhan, Nathan Herrmann, et al.
Frontiers in Medicine|February 9, 2023
Hair regrowth treatment efficacy and resistance in androgenetic alopecia: A systematic review and continuous Bayesian network meta-analysisPeter R Feldman, Pietro Gentile, Charles Piwko, et al.
Pageof 1